Replies to post #15027 on Delcath Systems Inc (DCTH)

[SAMNOTSAMUEL]

I will consider CS a big success if achieves $200M rev annually and at that what year, also beyond om, icc, and maybe cm (cutaneous melanoma) the rest of liver cancer market more doubtful